E852-1373 Screening compound: N6-benzyl-5,6-dimethyl-4-oxo-N2-[3-(4-propylpiperazin-1-yl)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-2,6-dicarboxamide

E852-1373 Screening compound: N6-benzyl-5,6-dimethyl-4-oxo-N2-[3-(4-propylpiperazin-1-yl)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-2,6-dicarboxamide
E852-1373 Screening compound: N6-benzyl-5,6-dimethyl-4-oxo-N2-[3-(4-propylpiperazin-1-yl)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-2,6-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E852-1373
N6-benzyl-5,6-dimethyl-4-oxo-N2-[3-(4-propylpiperazin-1-yl)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-2,6-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E852-1373

Molecular Formula

C27H39N7O3 (C27 H39 N7 O3)

Compound Name

N6-benzyl-5,6-dimethyl-4-oxo-N2-[3-(4-propylpiperazin-1-yl)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-2,6-dicarboxamide

IUPAC name

N6-benzyl-56-dimethyl-4-oxo-N2-[3-(4-propylpiperazin-1-yl)propyl]-4H5H6H7H-pyrazolo[15-a]pyrazine-26-dicarboxamide

SMILES

CCCN1CCN(CCCNC(c2nn(CC(C)(C(NCc3ccccc3)=O)N(C)C3=O)c3c2)=O)CC1

InChI

InChI=1S/C27H39N7O3/c1-4-12-32-14-16-33(17-15-32)13-8-11-28-24(35)22-18-23-25(36)31(3)27(2,20-34(23)30-22)26(37)29-19-21-9-6-5-7-10-21/h5-7,9-10,18H,4,8,11-17,19-20H2,1-3H3,(H,28,35)(H,29,37)/t27-/m0/s1

InChI Key

SMHACLCQNYZSSL-MHZLTWQESA-N

MDL Number (MFCD)

MFCD14922119

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

509.65

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.893

Distribution Coefficient, logD

-0.072

Water Solubility, LogSw

-2.03

Polar Surface Area

85.810

Acid Dissociation Constant (pKa)

12.33

Base Dissociation Constant (pKb)

8.31

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.60

E852-1373 in Drug Discovery

Included in Screening Libraries

Cyclic Ugi PPI Library (9586 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Infections
  • Immune system
  • animal
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with E852-1373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E852-1373?
Check Price and Availability of E852-1373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E852-1373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E852-1373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E852-1373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E852-1373 available by request